Syngene International Limited

BSE: SYNGENE539268ISIN INE398R01022

Healthcare
Healthcare Research, Analytics & Technology
BSE 500

Share price

₹417.20+10.90 (+2.68%)

as of 4 Nov 2026

Prices adjusted for splits and bonuses; cash dividends excluded. Volume shows actual shares traded.

52W high: ₹678.00
52W low: ₹344.85
Off 52W high: -38.47%
1M return: +16.68%
3M return: +2.61%
6M return: -7.36%
1Y return: -35.44%
20D avg volume: 2,26,117
50 DMA: ₹384.30
200 DMA: ₹427.22

Key ratios Consolidated

Market cap: ₹16,841 Cr
Current price: ₹417.20
52W high / low: ₹678.00 / ₹344.85
Face value: ₹10.00
P/E: 90.49
P/B: 3.47
EPS (TTM): ₹4.61
Book value / share: ₹120.36
ROE: —
ROCE: 8.40%
Operating margin: —
Net margin: —
Debt / equity: 0.00
Net debt: ₹-219.20 Cr
Interest cover: 9.42
Dividend yield: 0.30%
Dividend / share (TTM): ₹1.25
Payout: 27.11%
Cash conversion cycle: 29.6 days

Financials

Metric	Q2 FY27	Q1 FY27	Q4 FY26	Q3 FY26	Q2 FY26	Q1 FY26	Q4 FY25	Q3 FY25	Q2 FY25	Q1 FY25	Q4 FY24	Q3 FY24
Income statement
	832.70	736.00	1,036	917.10	910.60	874.50	1,018	943.70	891.00	789.70	916.90	853.50
	28.00	25.30	22.20	15.40	15.40	17.70	18.90	18.30	16.50	18.10	16.10	29.30
	860.70	761.30	1,059	932.50	926.00	892.20	1,037	962.00	907.50	807.80	933.00	882.80
	807.00	767.00	856.70	833.50	840.80	790.90	796.40	781.20	770.20	738.50	724.00	740.90
	203.00	178.20	223.30	220.90	227.50	239.50	228.10	241.90	230.80	168.00	172.10	240.30
	0.00	0.00	0.00	0.00	0.00	0.00	0.00	—	—	—	—	—
	272.70	259.10	300.80	267.40	275.00	261.70	253.00	249.50	251.50	229.90	226.90	220.90
	10.00	9.60	12.10	11.90	13.20	11.60	15.90	12.40	13.10	11.70	12.90	10.80
	111.70	112.20	111.50	113.70	116.50	111.20	106.10	108.70	110.90	106.90	111.10	108.10
	214.00	212.70	199.20	211.10	197.60	188.80	186.40	174.90	162.40	153.20	160.30	151.30
	53.70	-5.70	202.00	99.00	85.20	101.30	240.50	180.80	137.30	69.30	209.00	141.90
	-6.70	-13.50	-6.00	-70.60	0.00	0.00	0.00	0.00	0.00	32.00	0.00	-3.70
	47.00	-19.20	196.00	28.40	85.20	101.30	240.50	180.80	137.30	101.30	209.00	138.20
	14.80	-10.20	48.10	13.40	18.10	14.60	57.20	49.70	31.20	25.60	20.40	26.70
	32.20	-9.00	147.90	15.00	67.10	86.70	183.30	131.10	106.10	75.70	188.60	111.50
	0.80	-0.22	3.68	0.37	1.67	2.16	4.56	3.27	2.64	1.89	4.70	2.78
Key metrics
	168.70	102.60	319.60	154.00	214.90	224.10	362.50	301.90	261.30	219.90	333.00	257.10
	20.30%	13.90%	30.80%	16.80%	23.60%	25.60%	35.60%	32.00%	29.30%	27.80%	36.30%	30.10%
	3.90%	-1.20%	14.30%	1.60%	7.40%	9.90%	18.00%	13.90%	11.90%	9.60%	20.60%	13.10%
	1.00%	—	3.80%	—	1.80%	—	4.70%	—	—	—	—	—
	-8.60%	-15.80%	1.80%	-2.80%	2.20%	10.70%	11.00%	10.60%	—	—	—	—
	-52.00%	-110.40%	-19.30%	-88.60%	-36.80%	14.50%	-2.80%	17.60%	—	—	—	—

Metric	TTM	FY26	FY25	FY24	FY23	FY22	FY21	FY20	FY19	FY18
Income statement
	3,522	3,739	3,642	3,489	3,193	2,604	2,184	2,012	1,826	1,423
	90.90	70.70	71.80	90.60	70.90	52.80	64.60	81.60	75.10	61.80
	3,613	3,809	3,714	3,579	3,264	2,657	2,249	2,094	1,901	1,485
	3,264	3,322	3,086	2,947	2,670	2,142	1,815	1,648	1,485	1,112
	825.40	911.20	925.40	873.60	902.20	770.60	551.70	518.60	505.30	—
	0.00	0.00	0.00	—	—	—	—	—	—	—
	1,100	1,105	983.90	888.70	841.70	718.10	660.20	580.40	472.70	379.60
	43.60	48.80	53.10	47.20	45.20	24.10	27.70	34.60	32.30	22.70
	449.10	452.90	432.60	425.90	366.50	309.70	274.50	219.30	164.20	—
	837.00	796.70	674.20	599.50	514.80	395.80	342.90	308.60	282.90	270.90
	349.00	487.50	627.90	631.90	593.60	515.10	434.20	445.60	415.40	372.50
	-96.80	-76.60	32.00	-11.10	0.00	-30.70	35.00	71.30	0.00	0.00
	252.20	410.90	659.90	620.80	593.60	484.40	469.20	516.90	415.40	372.50
	66.10	94.20	163.70	110.80	129.20	88.60	64.30	104.80	83.80	67.10
	186.10	316.70	496.20	510.00	464.40	395.80	404.90	412.10	331.60	305.40
	4.63	7.87	12.35	12.71	11.59	9.94	10.18	10.38	16.77	—
Key metrics
	744.90	912.60	1,146	1,094	1,005	818.20	771.40	770.80	611.90	395.20
	21.15%	24.40%	31.50%	31.40%	31.50%	31.40%	35.30%	38.30%	33.50%	27.80%
	5.28%	8.50%	13.60%	14.60%	14.50%	15.20%	18.50%	20.50%	18.20%	21.50%
	—	8.40%	13.20%	—	—	—	—	—	—	—
	-5.99%	2.60%	4.40%	9.30%	22.60%	19.20%	8.60%	10.20%	28.30%	—
	-60.25%	-36.20%	-2.70%	9.80%	17.30%	-2.20%	-1.70%	24.30%	8.60%	—
	—	571.20	407.30	—	—	—	—	—	—	—
	—	2.89	2.35	—	—	—	—	—	—	—
	—	0.00	0.03	—	—	—	—	—	—	—
	—	-219.20	-247.50	—	—	—	—	—	—	—
	—	29.6	33.1	—	—	—	—	—	—	—
Balance sheet
	—	7,055	6,796	—	—	—	—	—	—	—
	—	2,143	2,287	—	—	—	—	—	—	—
	—	228.60	367.10	—	—	—	—	—	—	—
	—	508.80	526.70	—	—	—	—	—	—	—
	—	141.30	155.50	—	—	—	—	—	—	—
	—	166.30	130.00	—	—	—	—	—	—	—
	—	2,545	2,323	—	—	—	—	—	—	—
	—	347.50	352.00	—	—	—	—	—	—	—
	—	1,552	1,396	—	—	—	—	—	—	—
	—	9.40	119.60	—	—	—	—	—	—	—
	—	9.40	119.60	—	—	—	—	—	—	—
	—	0.00	0.00	—	—	—	—	—	—	—
	—	4,839	4,727	—	—	—	—	—	—	—
Cash flow
	—	915.20	1,168	—	—	—	—	—	—	—
	—	-860.40	-744.70	—	—	—	—	—	—	—
	—	-215.00	-141.80	—	—	—	—	—	—	—
	—	344.00	760.30	—	—	—	—	—	—	—

Metric	Q2 FY27	Q1 FY27	Q4 FY26	Q3 FY26	Q2 FY26	Q1 FY26	Q4 FY25	Q3 FY25	Q2 FY25	Q1 FY25	Q4 FY24	Q3 FY24
Income statement
	777.90	663.00	960.00	834.40	830.10	799.30	948.40	877.10	821.30	726.50	864.70	791.90
	27.50	24.80	21.60	14.50	14.20	16.60	18.40	18.00	16.40	17.70	15.30	28.80
	805.40	687.80	981.60	848.90	844.30	815.90	966.80	895.10	837.70	744.20	880.00	820.70
	729.70	684.30	777.50	753.00	760.10	731.70	738.10	725.30	713.40	677.40	669.60	692.30
	187.20	158.50	202.20	197.90	201.20	223.00	212.80	229.10	216.20	210.20	162.40	227.60
	0.00	0.00	0.00	0.00	0.00	0.00	0.00	—	—	—	—	—
	228.00	207.00	248.50	217.50	225.90	212.60	209.40	212.60	224.10	195.60	195.10	196.50
	4.10	4.10	6.50	6.20	7.40	5.90	10.10	6.70	7.00	7.40	8.50	6.30
	95.10	95.60	95.30	97.10	100.10	94.60	89.60	92.30	93.70	91.70	95.70	93.60
	219.50	223.90	215.20	225.80	214.50	217.50	209.20	190.30	170.60	160.80	167.20	158.70
	75.70	3.50	204.10	95.90	84.20	84.20	228.70	169.80	124.30	66.80	210.40	128.40
	-6.70	-13.50	-7.40	-65.80	0.00	0.00	0.00	—	—	32.00	—	-3.70
	69.00	-10.00	196.70	30.10	84.20	84.20	228.70	169.80	124.30	98.80	210.40	124.70
	20.30	-7.90	48.50	13.60	18.00	10.20	54.30	46.70	27.70	24.90	20.60	24.90
	48.70	-2.10	148.20	16.50	66.20	74.00	174.40	123.10	96.60	73.90	189.80	99.80
	1.21	-0.05	3.68	0.41	1.65	1.84	4.34	3.07	2.41	1.84	4.73	2.49
Key metrics
	168.20	89.70	298.50	133.40	191.70	184.70	328.40	268.80	225.00	197.90	314.60	224.60
	21.60%	13.50%	31.10%	16.00%	23.10%	23.10%	34.60%	30.60%	27.40%	27.20%	36.40%	28.40%
	6.30%	-0.30%	15.40%	2.00%	8.00%	9.30%	18.40%	14.00%	11.80%	10.20%	21.90%	12.60%
	1.40%	—	4.00%	—	1.80%	—	4.70%	—	—	—	—	—
	-6.30%	-17.10%	1.20%	-4.90%	1.10%	10.00%	9.70%	10.80%	—	—	—	—
	-26.40%	-102.80%	-15.00%	-86.60%	-31.50%	0.10%	-8.10%	23.30%	—	—	—	—

Metric	TTM	FY26	FY25	FY24	FY23	FY22	FY21	FY20	FY19	FY18
Income statement
	3,235	3,424	3,373	3,203	3,194	2,601	2,179	2,012	1,826	1,423
	88.40	66.90	70.50	88.00	70.90	52.80	64.60	81.60	75.10	61.80
	3,324	3,491	3,444	3,291	3,264	2,654	2,244	2,094	1,901	1,485
	2,944	3,022	2,854	2,723	2,664	2,142	1,812	1,649	1,486	1,113
	745.80	824.30	868.30	839.10	902.20	770.60	551.70	518.60	505.30	—
	0.00	0.00	0.00	—	—	—	—	—	—	—
	901.00	904.50	841.70	761.20	812.20	697.80	641.50	572.20	465.40	376.90
	20.90	26.00	31.20	29.50	45.20	24.10	27.70	34.60	32.30	22.70
	383.10	387.10	367.30	368.90	359.10	309.70	274.50	219.30	164.20	131.40
	884.40	873.00	728.60	611.20	545.00	416.00	358.50	318.00	—	274.00
	379.20	468.40	589.60	568.40	600.90	512.40	432.40	444.40	414.20	372.10
	-93.40	-73.20	32.00	-11.10	—	-30.70	35.00	71.30	—	—
	285.80	395.20	621.60	557.30	600.90	481.70	467.40	515.70	414.20	372.10
	74.50	90.30	153.60	90.80	127.90	87.90	63.70	104.20	83.50	67.00
	211.30	304.90	468.00	466.50	473.00	393.80	403.70	411.50	330.70	305.10
	5.25	7.58	11.64	11.62	11.81	9.89	10.15	10.36	16.72	—
Key metrics
	689.80	808.30	1,020	955.70	1,005	815.50	769.60	769.60	610.70	526.20
	21.32%	23.60%	30.20%	29.80%	31.50%	31.30%	35.30%	38.30%	33.50%	37.00%
	6.53%	8.90%	13.90%	14.60%	14.80%	15.10%	18.50%	20.50%	18.10%	21.40%
	—	8.20%	12.90%	—	—	—	—	—	—	—
	-6.36%	1.50%	5.30%	0.30%	22.80%	19.40%	8.30%	10.20%	28.30%	—
	-51.72%	-34.90%	0.30%	-1.40%	20.10%	-2.50%	-1.90%	24.40%	8.40%	—
	—	567.20	744.50	—	—	—	—	—	—	—
	—	2.73	2.38	—	—	—	—	—	—	—
	—	0.00	0.02	—	—	—	—	—	—	—
	—	-120.50	-131.00	—	—	—	—	—	—	—
	—	27.7	29.6	—	—	—	—	—	—	—
Balance sheet
	—	6,563	6,407	—	—	—	—	—	—	—
	—	1,876	2,034	—	—	—	—	—	—	—
	—	120.50	233.50	—	—	—	—	—	—	—
	—	432.50	469.40	—	—	—	—	—	—	—
	—	136.90	150.30	—	—	—	—	—	—	—
	—	101.00	71.20	—	—	—	—	—	—	—
	—	2,244	1,994	—	—	—	—	—	—	—
	—	310.00	346.50	—	—	—	—	—	—	—
	—	1,419	1,329	—	—	—	—	—	—	—
	—	0.00	102.50	—	—	—	—	—	—	—
	—	0.00	102.50	—	—	—	—	—	—	—
	—	0.00	0.00	—	—	—	—	—	—	—
	—	4,704	4,639	—	—	—	—	—	—	—
Cash flow
	—	831.00	1,114	—	—	—	—	—	—	—
	—	-783.80	-810.40	—	—	—	—	—	—	—
	—	-177.80	-136.50	—	—	—	—	—	—	—
	—	263.80	369.30	—	—	—	—	—	—	—

Compounded growth

Standalone

Sales CAGR 3Y: +2.35%
Sales CAGR 5Y: +9.45%
Profit CAGR 3Y: -13.62%
Profit CAGR 5Y: -5.46%
Sales YoY (TTM): -6.36%
Profit YoY (TTM): -51.72%

Consolidated

Sales CAGR 3Y: +5.40%
Sales CAGR 5Y: +11.35%
Profit CAGR 3Y: -11.98%
Profit CAGR 5Y: -4.79%
Sales YoY (TTM): -5.99%
Profit YoY (TTM): -60.25%

Compounded from reported annual figures. We publish no share-price CAGR: our prices are as-traded, so one would be wrong across every split and bonus issue.

Shareholding as of 30 Sep 2026

Promoter holding: 52.59%

Quarter	September 2026	June 2026
Promoter %	52.59%	52.59%

Holder	Type	Holding	Previous	Change
BIOCON LIMITED	Promoter	52.32%	52.32%	0.00%
NIPPON LIFE INDIA TRUSTEE LTD-A/C NIPPON INDIA PHA	Public	8.00%	—	—
ICICI PRUDENTIAL MNC FUND	Public	6.82%	—	—
DSP NIFTY 500 INDEX FUND	Public	4.71%	—	—
SBI NIFTY SMALLCAP 250 ETF	Public	3.10%	—	—
LIFE INSURANCE CORPORATION OF INDIA	Public	1.78%	1.78%	0.00%
GOVERNMENT OF SINGAPORE	Public	1.16%	2.13%	-0.97%
MIRAE ASSET FOCUSED FUND	Public	1.05%	—	—
TATA INDIA INNOVATION FUND	Public	1.02%	—	—
BIOCON LIMITED EMPLOYEE WELFARE TRUST	Promoter Group	0.26%	—	—
KIRAN MAZUMDAR SHAW	Promoter Group	0.01%	0.01%	0.00%
DEV MAZUMDAR	Promoter Group	0.00%	0.00%	0.00%
BIOCON RESEARCH LIMITED	Promoter Group	0.00%	0.00%	0.00%
RAVI RASENDRA MAZUMDAR	Promoter Group	0.00%	0.00%	0.00%

Public shareholders are disclosed individually only above 1%.

Peer comparison

Company	Mkt cap (₹ Cr)	Price (₹)	P/E	ROCE	Sales YoY	Profit YoY	1Y return
Syngene International Limited	16,841	417.20	90.49	8.40%	-5.99% TTM	-60.25% TTM	-35.44%
Indegene Limited	14,870	617.05	36.17	15.40%	+35.84% TTM	-7.78% TTM	+14.61%
Suven Life Sciences Ltd.	7,803	276.15	-22.14	-46.50%	+17.29% TTM	-91.30% TTM	+40.18%
Vimta Labs Ltd.	2,230	498.80	—	—	+4.90% TTM	+48.48% TTM	-24.58%
NOVELIX PHARMACEUTICALS LIMITED S	194	68.00	53.54	6.70%	+179.89% TTM	+535.09% TTM	+29.52%
Bilcare Ltd.	183	77.69	16.51	9.20%	+11.44% TTM	+125.02% TTM	-25.62%
TAKE LIMITED S	170	11.47	29.00	11.10%	-15.35% TTM	+124.35% TTM	-52.11%
Jeevan Scientific Technology Limited	164	81.70	32.02	4.80%	+66.05% TTM	+222.49% TTM	+30.72%
GlobalSpace Technologies Limited	99	28.84	29.21	5.00%	+37.21% TTM	+398.53% TTM	+63.12%
Adeshwar Meditex Limited S	27	18.80	21.36	6.00%	—	—	+1.62%
Vanta Bioscience Limited	14	20.39	—	1.50%	—	—	-5.86%

Filings & corporate actions

Recent announcements

Intimation of Earnings Conference call transcript for Q2 FY20272 Nov 2026 · Company Update / Analyst / Investor Meet
Newspaper Advertisement - Financial Results29 Oct 2026 · Company Update / Newspaper Publication
Intimation of audio recording for Q2 FY27 post-earnings call28 Oct 2026 · Company Update / Analyst / Investor Meet
Investor Presentation27 Oct 2026 · Company Update / Investor Presentation
Press Release27 Oct 2026 · Company Update / Press Release / Media Release
Change in Management27 Oct 2026 · Company Update / Change in Management
Results- Financial Results for September 30, 2026.27 Oct 2026 · Result / Financial Results
Outcome of Board Meeting27 Oct 2026 · Board Meeting / Outcome of Board Meeting
Intimation of Conference Call for Analysts and Investors17 Oct 2026 · Company Update / Analyst / Investor Meet
Certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulation, 2018.8 Oct 2026 · Company Update / Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Syngene International Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 27/10/2026 ,inter alia, to consider and approve the Un-Audited Standalone ....8 Oct 2026 · Board Meeting / Board Meeting
Intimation of Closure of Trading Window25 Sep 2026 · Insider Trading / SAST / Closure of Trading Window
Intimation of cancellation of meeting with Analyst/Institutional Investors24 Sep 2026 · Company Update / General
Resignation of Mr. Pramuch Goel as Head Corporate Affairs & Communications and a member of Executive Committee (Senior Management Personnel) of the Company w.e.f. the close of business ....21 Sep 2026 · Company Update / Change in Management
Intimation of Schedule of Meeting with Analyst/Institutional Investor21 Sep 2026 · Company Update / Analyst / Investor Meet
Intimation of Schedule of Meeting with Analyst/Institutional Investor12 Sep 2026 · Company Update / Analyst / Investor Meet
Intimation of Schedule of Meeting with Analyst/Institutional Investor11 Sep 2026 · Company Update / Analyst / Investor Meet
Communication regarding remittance of final dividend for the FY 2025-2610 Sep 2026 · Company Update / General
Grant of Performance Share Units under Syngene Long Term Incentive Performance Share Plan (PSP) 2023 ("Plan")1 Sep 2026 · Company Update / General
Intimation of Schedule of Investor/Analyst Meeting with Goldman Sachs Asia Leaders Conference 202625 Aug 2026 · Company Update / Analyst / Investor Meet
Intimation of investment in Ampin C&I Power Twelve Private Limited24 Aug 2026 · Company Update / Acquisition
Intimation of Investor call schedule with Entrust Family Office24 Aug 2026 · Company Update / Analyst / Investor Meet
Intimation of Schedule of Meeting with Analyst/Institutional Investor on August 13, 2026 and August 14, 2026.10 Aug 2026 · Company Update / Analyst / Investor Meet
Intimation of Earnings Conference call transcript for Q1 FY20276 Aug 2026 · Company Update / Analyst / Investor Meet
Scrutinizer''s Report and voting results of 33rd Annual General Meeting31 Jul 2026 · AGM/EGM / AGM
Intimation of audio recording for Q1 FY27 post-earnings call30 Jul 2026 · Company Update / Analyst / Investor Meet
Newspaper Advertisement - Financial Results30 Jul 2026 · Company Update / Newspaper Publication
Investor Presentation29 Jul 2026 · Company Update / Investor Presentation
Proceedings of the 33rd Annual General Meeting29 Jul 2026 · AGM/EGM / AGM
Resignation of Independent Director29 Jul 2026 · Company Update / Change in Management
Press Release29 Jul 2026 · Company Update / Press Release / Media Release
Results - Financial Results for quarter ended June 30, 202629 Jul 2026 · Result / Financial Results
Outcome of the Board Meeting held on July 29, 202629 Jul 2026 · Board Meeting / Outcome of Board Meeting
Intimation of Conference Call with Analysts and Investors.22 Jul 2026 · Company Update / Analyst / Investor Meet
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Mirae Asset Mutual Fund22 Jul 2026 · Insider Trading / SAST / Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
Change in Senior Managerial Personnel14 Jul 2026 · Company Update / Change in Management
Certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018.10 Jul 2026 · Company Update / Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Syngene International Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/07/2026 ,inter alia, to consider and approve the un-audited Standalone ....8 Jul 2026 · Board Meeting / Board Meeting
Resignation of Statutory Auditor of material subsidiary8 Jul 2026 · Company Update / Resignation of Statutory Auditors
Disclosure under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 20157 Jul 2026 · Company Update / General

Corporate actions

Purpose	Ex date	Record date	Payment date
Final Dividend - Rs. - 1.2500	25 Jun 2026	26 Jun 2026	—
Final Dividend - Rs. - 1.2500	27 Jun 2025	27 Jun 2025	—
Final Dividend - Rs. - 1.2500	28 Jun 2024	28 Jun 2024	—

Board meetings

27 Oct 2026 Board Meeting - Financial Results
29 Jul 2026 Board Meeting - Financial Results